Home » U.S. FDA Guidance Covers Postapproval Study Reports for Device Clinical Trials
U.S. FDA Guidance Covers Postapproval Study Reports for Device Clinical Trials
February 6, 2007
Device clinical trial sponsors will be subject to new requirements under U.S. Food and Drug Administration (FDA) draft guidance on the format, content and review of reports related to clinical postapproval studies.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor